Open Access

[Corrigendum] Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway

  • Authors:
    • Yingshan Liu
    • Yan Zhang
    • Kun Jia
    • Yuhao Dong
    • Weiyuan Ma
  • View Affiliations

  • Published online on: May 16, 2022     https://doi.org/10.3892/etm.2022.11372
  • Article Number: 445
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

July-2022
Volume 24 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu Y, Zhang Y, Jia K, Dong Y and Ma W: [Corrigendum] Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway. Exp Ther Med 24: 445, 2022
APA
Liu, Y., Zhang, Y., Jia, K., Dong, Y., & Ma, W. (2022). [Corrigendum] Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway. Experimental and Therapeutic Medicine, 24, 445. https://doi.org/10.3892/etm.2022.11372
MLA
Liu, Y., Zhang, Y., Jia, K., Dong, Y., Ma, W."[Corrigendum] Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway". Experimental and Therapeutic Medicine 24.1 (2022): 445.
Chicago
Liu, Y., Zhang, Y., Jia, K., Dong, Y., Ma, W."[Corrigendum] Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway". Experimental and Therapeutic Medicine 24, no. 1 (2022): 445. https://doi.org/10.3892/etm.2022.11372